Inhibitor Therapeutics (INTI) Other non-cash items (2012 - 2026)
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Other non-cash items (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Inhibitor Therapeutics | 19.12 Mn | 11.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 |
| Mar 31, 2026 | 159.00 |
| Dec 31, 2025 | 237.00 |
| Sep 30, 2025 | 238.00 |
| Jun 30, 2025 | 237.00 |
| Mar 31, 2025 | 80.00 |
| Dec 31, 2014 | 10,153.00 |
| Jun 30, 2014 | 18,000.00 |
| Mar 31, 2014 | 6,666.00 |
| Dec 31, 2013 | 333,352.00 |
| Sep 30, 2013 | -333,352.00 |
| Jun 30, 2013 | 166,676.00 |
| Dec 31, 2012 | 20,833.00 |
API Access
Inhibitor Therapeutics Other non-cash items API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-cash-items", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();